Description

Amediplase CAS NO 151912-11-7 is a high-purity, recombinant pharmaceutical compound belonging to the class of thrombolytic agents. This product is critical for advanced medical research and therapeutic development, offering a reliable standard for efficacy and safety studies. It is primarily utilized by pharmaceutical manufacturers, biotechnology research institutions, and clinical diagnostic developers focused on cardiovascular and hematological applications.

Application

• Primary active pharmaceutical ingredient (API) in thrombolytic drug formulations.
• Reference standard for quality control and analytical method development in pharmaceutical manufacturing.
• Key reagent in preclinical and clinical research for studying fibrinolysis and clot dissolution mechanisms.
• Essential component in the development of in-vitro diagnostic (IVD) kits for thrombotic disorders.
• Used in biochemical research to investigate serine protease activity and enzyme kinetics.
• Critical material for process development and scale-up in biopharmaceutical production.

Basic Information

Product Name	Amediplase
CAS No.	151912-11-7
Molecular Formula	Contact for details
Molecular Weight	Contact for details
Synonyms	Recombinant Amediplase; Plasminogen Activator Amediplase; Thrombolytic Protein Amediplase; rAmediplase; BM 06.022; Recombinant Plasminogen Activator; Saruplase; Pro-urokinase (recombinant)
EINECS	Contact for details

Quality Control

Our Amediplase is manufactured under strict quality systems. Each batch undergoes comprehensive analytical testing, including purity assay, biological activity determination, and impurity profiling, to ensure it meets the stringent requirements for pharmaceutical use. Certificates of Analysis (COA) documenting compliance with relevant specifications are available upon request.

Storage

Preserve in a tightly closed container, protected from light. For long-term stability, store at -20°C or below. Allow the product to equilibrate to room temperature before opening to minimize moisture condensation. Store in a dedicated freezer away from volatile substances.

Specification

Item	Specification
Appearance	White to off-white lyophilized powder
Identification (HPLC/MS)	Conforms
Purity (HPLC)	≥ 98.0%
Biological Activity	≥ 100,000 IU/mg
Protein Content	≥ 95.0%
Endotoxin	< 1.0 EU/mg
Residual Moisture (KF)	< 3.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.